Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life — Stella

Home/Type 1 Diabetes/PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

View on ClinicalTrials.gov

Recruiting

Back to Type 1 Diabetes trials

PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

Trial locations(4 sites)

United States

University of Colorado, Aurora, Colorado

Joslin Diabetes Center, Boston, Massachusetts

Mt Sinai, New York, New York

Ohio State University, Columbus, Ohio

Key details

Sponsor

University of Colorado, Denver

Collaborators

Joslin Diabetes Center, Ohio State University

Enrollment target

~6,000 participants

Started

December 2022

Primary completion

November 2032

Age range

0 Days – 99 Years

Last updated November 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.